New hope for stuck on the transplant waitlist
NCT ID NCT05017545
Summary
This study is testing whether two drugs, carfilzomib and belatacept, can help people who have been waiting a very long time for a kidney transplant. These patients have immune systems that attack most donor kidneys, making it extremely hard to find a match. The goal is to see if this drug combination can safely lower those immune attacks, making more donor kidneys compatible and shortening the wait.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGHLY SENSITIZED PROSPECTIVE KIDNEY TRANSPLANT RECIPIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Transplant Center, Duke University Medical Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.